Eosinophilic Granulomatosis with Polyangiitis (EGPA)
If you are interested in any of our research studies, please contact our research group at 215-614-4417 or email us at rheumatologyresearch@uphs.upenn.edu.
|
Study Name |
Medication Involved |
Disease Studied |
Currently Enrolling |
|---|---|---|---|
| Benralizumab in eosinophilic granulomatosis with polyangiitis (EGPA) (MANDARA) | YES | EGPA | NO |
| Nasal Microbiome in ANCA Associated Vasculitis and Relapsing Polychondritis (NMB) | NO | GPA, MPA, EGPA, & RP | YES (EGPA & RP) |
| 5506: The EGPA Registry | NO | EGPA | YES |
| Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc) | YES | GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN | YES |
| One-Time DNA Study for Vasculitis (OTD) | NO | GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN | YES |
| Clinical Transcriptomics in Systemic Vasculitis (CUTIS) | NO | GPA, MPA, EGPA, PAN, IgAV, cryoglobulinemic, drug-induced, isolated cutaneous small vessel vasculitis, urticarial | YES |
| Tissue Repository Collection Protocol | NO | GPA, MPA, EGPA, GCA, Takayasu's arteritis, PAN, cutaneous vasculitis | YES |